By
Kyle Brasseur2023-10-26T19:08:00
The Department of Justice (DOJ) is sticking with David Fuhr as permanent head of its Foreign Corrupt Practices Act (FCPA) Unit.
Fuhr had the “acting” removed from his title on Oct. 10, a DOJ spokesperson confirmed. Fuhr had been serving as acting chief of the FCPA Unit, which is housed under the DOJ’s Fraud Section, since May, when his predecessor David Last departed the agency.
Last has since joined law firm Cleary Gottlieb as a partner.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2023-11-08T16:54:00Z By Kyle Brasseur
A new Foreign Corrupt Practices Act review by the Department of Justice offers an example of when stipends paid to foreign government personnel would not be considered a violation of the anti-bribery provisions of the law.
2023-10-12T16:00:00Z By Kyle Brasseur
All the carrots being offered by the Department of Justice in the past year—greater penalty reduction thresholds, relief related to compensation clawbacks, voluntary self-disclosure incentives—are part of a strategy to strengthen the enforcement stick when companies don’t cooperate.
2023-10-05T18:50:00Z By Kyle Brasseur
The Department of Justice’s push to incentivize companies to voluntarily self-disclose potential misconduct reached its next stage in the form of a safe harbor policy regarding mergers and acquisitions.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud